Product Highlight - Saxenda

Active ingredient: Liraglutide

Indications: An adjunct to a reduced-calorie diet & increased physical activity for wt management in adults w/ an initial BMI of ≥30 kg/m² (obesity), or ≥27 kg/m² to <30 kg/m² (overwt in the presence of at least 1 wt-related comorbidity eg, dysglycaemia (pre-diabetes or type 2 DM), HTN, dyslipidaemia or obstructive sleep apnoea. An adjunct to a healthy nutrition & increased physical activity for wt management in adolescents ≥12 yr w/ obesity (BMI corresponding to ≥30 kg/m² for adults by international cut-off points) & body wt >60 kg.

Posology and method of administration: SC Adult & adolescent 12-18 yr Initially 0.6 mg once daily, should be increased to 3 mg once daily in increments of 0.6 mg w/ at least 1 wk intervals. Maintenance: 3 mg daily.